Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Potency-Adjusted Analyses of a Head-to-Head Pharmacokinetic Study of Damoctocog Alfa Pegol (BAY 94-9027) and Efmoroctocog Alfa (rFVIIIFc) in Patients with Severe Hemophilia A

Alexander Solms, Anita Shah, Sara Wiegmann, Maurice Ahsman, Erik Berntorp, Andreas Tiede, MD, Alfonso Iorio, MDPhD, Maria Elisa Mancuso, Tihomir Zhivkov, Toshko Lissitchkov

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-136586

Published: 2020

Journal Articles

A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A

Andreas Tiede, MD, Georg Goldmann, Predrag S Miljić, Lars Korsholm, Irina Matytsina, Paula Persson, Toshko Jelev Lissitchkov, MD

Blood (2018) 132 (Supplement 1): 2491.

https://doi.org/10.1182/blood-2018-99-111269

Published: 2018

Journal Articles

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Blood (2018) 132 (Supplement 1): 2465.

https://doi.org/10.1182/blood-2018-99-113996

Published: 2018

Journal Articles

Novel Von Willebrand Factor (vWF) Fragment Supports Subcutaneous Administration of Factor VIII: Pharmacokinetic Data from Hemophilia A Mouse Model

Nadine Vollack, PhD, Sonja Werwitzke, MD PhD, Barbara A Solecka-Witulska, PhD, Christoph Kannicht, PhD, Andreas Tiede, MD

Blood (2017) 130 (Supplement 1): 4877.

https://doi.org/10.1182/blood.V130.Suppl_1.4877.4877

Published: 2017

Journal Articles

Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study

Katharina Holstein, MD, Andrea Smith, Paul Knöbl, MD PhD, Christiane Dobbelstein, MD, Wolfgang A. Miesbach, MD PhD, Michael Spannagl, MD PhD, Jürgen Heinz, MD PhD, Ute Scholz, MD, Hermann Eichler, MD, Angela Huth-Kühne, MD, Robert Klamroth, MD PhD, Armin Koch, MD PhD, Andreas Tiede, MD

Blood (2017) 130 (Supplement 1): 22.

https://doi.org/10.1182/blood.V130.Suppl_1.22.22

Published: 2017

Journal Articles

Diagnostic and Prognostic Value of Factor VIII Binding Antibodies in Acquired Hemophilia A: Data from the GTH-AH 01/2010 Study

Andreas Tiede, MD PhD, Sonja Werwitzke, MD PhD, Ulrich Geisen, MD PhD, Ulrike Nowak-Göttl, MD PhD, Hermann Eichler, MD PhD, Bernhard Stephan, MD, Ute Scholz, MD, Holstein Katharina, MD, Robert Klamroth, Paul Knöbl, MD PhD, Angela Huth-Kühne, MD, Barbara Bomke, MD

Blood (2015) 126 (23): 3515.

https://doi.org/10.1182/blood.V126.23.3515.3515

Published: 2015

Journal Articles

Frequency and Epitope Specificity of Anti-Factor VIII C1 Domain Antibodies in Acquired and Hereditary Hemophilia Inhibitor Patient Plasma

Joerg Kahle, PhD, Aleksander Orlowski, Anja Schmidt, PhD, Kerstin Brettschneider, Thomas Klingebiel, MD, John F Healey, BS, Ernest T Parker, BA, John (Pete) S Lollar, MD, Marc Jacquemin, MD, Manuela Krause, MD, Andreas Tiede, MD PhD, Dirk Schwabe, MD, Christoph Königs, MD PhD

Blood (2015) 126 (23): 3491.

https://doi.org/10.1182/blood.V126.23.3491.3491

Published: 2015

Journal Articles

Personalized Prophylaxis with Human-Cl Recombinant FVIII in HA Patients

Robert Klamroth, Toshko Lissitchkov, MD, Luminita Rusen, Olaf Walter, MD MBA, Johann Bichler, PhD, K John Pasi, Andreas Tiede, MD PhD, Sigurd Knaub, PhD

Blood (2015) 126 (23): 547.

https://doi.org/10.1182/blood.V126.23.547.547

Published: 2015

Journal Articles

Consumption Of FVIII Concentrate During On-Demand and Prophylactic Treatment With Human-cl rhFVIII In Prospective Clinical Studies In Adult Patients With Severe Hemophilia A

Andreas Tiede, MD, PhD, Sigurd Knaub, PhD, Johannes Oldenburg, MD, Johann Bichler, PhD

Blood (2013) 122 (21): 3595.

https://doi.org/10.1182/blood.V122.21.3595.3595

Published: 2013

Journal Articles

Comparison Of Autologous Microparticles and Fucosyltransferase-7 For Adhesion Improvement Of Hematopoietic Stem Cells To Bone Marrow Endothelial Cells In a Microfluidic Flow Chamber

Arne Trummer, MD, Dennis Rataj, Msc, Sonja Werwitzke, MD, PhD, Andreas Tiede, MD, PhD

Blood (2013) 122 (21): 2000.

https://doi.org/10.1182/blood.V122.21.2000.2000

Published: 2013

Journal Articles

Prevention Of Murine FVIII-Specific Memory B Cells Due To FcγR2B (CD32) Blockade Is Associated With Distinctive Alterations In The FVIII-Specific Cytokine Profile

Nadine Vollack, M.Sc., Arne Trummer, MD, Andreas Tiede, MD, PhD, Sonja Werwitzke, MD, PhD

Blood (2013) 122 (21): 572.

https://doi.org/10.1182/blood.V122.21.572.572

Published: 2013

Journal Articles

Prognostic Parameters For Remission Of and Survival In Acquired Hemophilia A: Results Of The GTH-AH 01/2010 Multicenter Study

Andreas Tiede, MD, PhD, Jan-Malte Blumtritt, Robert Klamroth, MD, PhD, Saskia Gottstein, MD, Katharina Holstein, MD, Jürgen Heinz, MD, Rüdiger E. Scharf, MD, PhD, Angela Huth-Kühne, MD, PhD, Joachim F. Schenk, MD, PhD, Richard Greil, MD, Wolfgang A. Miesbach, MD, PhD, Ralf Ulrich Trappe, MD, PhD, Ute Scholz, MD, Daniela Manner, MD, Peter Neumeister, MD, Charis von Auer-Wegener, MD, Ulrich Kalus, MD, Klaus Leimkühler, MD, Paul Knoebl, MD

Blood (2013) 122 (21): 205.

https://doi.org/10.1182/blood.V122.21.205.205

Published: 2013

Journal Articles

Deletion or Inhibition of Fc Gamma Receptor IIb (CD32) Prevents the Memory B Cell Response to Factor VIII in a Hemophilia A Mouse Model

Sonja Werwitzke, MD, PhD, Marcus von Hornung, PhD, Katy Kalippke, PhD, Arne Trummer, MD, Arnold Ganser, MD, Andreas Tiede, MD, PhD

Blood (2011) 118 (21): 204.

https://doi.org/10.1182/blood.V118.21.204.204

Published: 2011

Journal Articles

A Prospective, Multi-Center, Randomized Clinical Trial to Compare the Pharmacokinetic Properties of Human-Cl rhFVIII, a New Human-Cell Line Derived Recombinant Factor VIII, with Those of a Full-Length Recombinant Factor VIII Expressed in Baby Hamster Kidney Cells,

Sigurd Knaub, PhD, Andreas Tiede, MD, PhD, Toshko Lissitchkov, MD, PhD, Leonard A. Valentino, MD, FAAP, Jerry Sherman Powell, MD, Marilyn J. Manco-Johnson, MD

Blood (2011) 118 (21): 3309.

https://doi.org/10.1182/blood.V118.21.3309.3309

Published: 2011

Journal Articles

Endothelial Microparticles Improve Primary and Secondary Hemostasis in Patients with Von-Willebrand Disease

Arne Trummer, MD, Ingvild Birschmann, MD, PhD, Sonja Werwitzke, MD, PhD, Arnold Ganser, MD, Andreas Tiede, MD, PhD

Blood (2011) 118 (21): 2287.

https://doi.org/10.1182/blood.V118.21.2287.2287

Published: 2011

Journal Articles

Strategies for Securing and Maintaining Predictable Efficacy with Recombinant Activated Factor VII in On-Demand Treatment of Haemophilia Patients with Inhibitors.

Benny Sørensen, MD, Ph.D., Yesim Dargaud, Gili Kenet, MD, PhD, Jeanne M. Lusher, MD, Andrew Mumford, Steven W. Pipe, MD, Andreas Tiede, MD, PhD

Blood (2009) 114 (22): 4443.

https://doi.org/10.1182/blood.V114.22.4443.4443

Published: 2009

Journal Articles

Cardiovascular Interventions in Patients with Hemophilia and Severe Von Willebrand Disease.

Andreas Tiede, MD, PhD, Sonja R. Alesci, MD, Klamroth, MD, Katharina Holstein, MD, Manuela Krause, MD, Ronald Fischer, MD, Ute Scholz, MD, Johannes Oldenburg, MD, Silvia Horneff, MD

Blood (2008) 112 (11): 2281.

https://doi.org/10.1182/blood.V112.11.2281.2281

Published: 2008

Journal Articles

An Ex Vivo Perfusion Model To Study the Treatment of Thrombotic Microangiopathy during Pig-to-Human Xenogenic Kidney Transplantation.

Wolf Ramackers, Lars Friedrich, MD, Wolfgang Schüttler, PhD, Sabine Bergmann, Arnold Ganser, MD, Michael Winkler, MD, Andreas Tiede, MD, PhD

Blood (2007) 110 (11): 3190.

https://doi.org/10.1182/blood.V110.11.3190.3190

Published: 2007

Journal Articles

Diagnostic Workup of Patients with Acquired Von Willebrand’s Syndrome.

Andreas Tiede, MD, PhD, Jan Priesack, MD, Oliver Bolte, MD, Arne Trummer, MD, Katrin Bohlmann, Wiebke Helms, Arnold Ganser, MD, Roswith Eisert, MD

Blood (2006) 108 (11): 1045.

https://doi.org/10.1182/blood.V108.11.1045.1045

Published: 2006

Journal Articles

Platelet-Derived Microparticles Accelerate Engraftment of Peripheral Blood Stem Cells in Human Allogeneic Transplantation.

Christiane de Rop, Jan Priesack, MD, Andreas Tiede, MD, PhD, Arne Trummer, MD

Blood (2005) 106 (11): 3035.

https://doi.org/10.1182/blood.V106.11.3035.3035

Published: 2005

NARROW

Potency-Adjusted Analyses of a Head-to-Head Pharmacokinetic Study of Damoctocog Alfa Pegol (BAY 94-9027) and Efmoroctocog Alfa (rFVIIIFc) in Patients with Severe Hemophilia A

A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Novel Von Willebrand Factor (vWF) Fragment Supports Subcutaneous Administration of Factor VIII: Pharmacokinetic Data from Hemophilia A Mouse Model

Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study

Diagnostic and Prognostic Value of Factor VIII Binding Antibodies in Acquired Hemophilia A: Data from the GTH-AH 01/2010 Study

Frequency and Epitope Specificity of Anti-Factor VIII C1 Domain Antibodies in Acquired and Hereditary Hemophilia Inhibitor Patient Plasma

Personalized Prophylaxis with Human-Cl Recombinant FVIII in HA Patients

Consumption Of FVIII Concentrate During On-Demand and Prophylactic Treatment With Human-cl rhFVIII In Prospective Clinical Studies In Adult Patients With Severe Hemophilia A

Comparison Of Autologous Microparticles and Fucosyltransferase-7 For Adhesion Improvement Of Hematopoietic Stem Cells To Bone Marrow Endothelial Cells In a Microfluidic Flow Chamber

Prevention Of Murine FVIII-Specific Memory B Cells Due To FcγR2B (CD32) Blockade Is Associated With Distinctive Alterations In The FVIII-Specific Cytokine Profile

Prognostic Parameters For Remission Of and Survival In Acquired Hemophilia A: Results Of The GTH-AH 01/2010 Multicenter Study

Deletion or Inhibition of Fc Gamma Receptor IIb (CD32) Prevents the Memory B Cell Response to Factor VIII in a Hemophilia A Mouse Model

A Prospective, Multi-Center, Randomized Clinical Trial to Compare the Pharmacokinetic Properties of Human-Cl rhFVIII, a New Human-Cell Line Derived Recombinant Factor VIII, with Those of a Full-Length Recombinant Factor VIII Expressed in Baby Hamster Kidney Cells,

Endothelial Microparticles Improve Primary and Secondary Hemostasis in Patients with Von-Willebrand Disease

Strategies for Securing and Maintaining Predictable Efficacy with Recombinant Activated Factor VII in On-Demand Treatment of Haemophilia Patients with Inhibitors.

Cardiovascular Interventions in Patients with Hemophilia and Severe Von Willebrand Disease.

An Ex Vivo Perfusion Model To Study the Treatment of Thrombotic Microangiopathy during Pig-to-Human Xenogenic Kidney Transplantation.

Diagnostic Workup of Patients with Acquired Von Willebrand’s Syndrome.

Platelet-Derived Microparticles Accelerate Engraftment of Peripheral Blood Stem Cells in Human Allogeneic Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only